Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
AHA recognizes UC Irvine Medical Center's commitment to high-quality cardiac care

AHA recognizes UC Irvine Medical Center's commitment to high-quality cardiac care

Genentech confirms EMA, FDA updates on Avastin for metastatic breast cancer

Genentech confirms EMA, FDA updates on Avastin for metastatic breast cancer

Study suggests blood test may detect persons with CKD

Study suggests blood test may detect persons with CKD

Reuters rates hospitals' cardiovascular program

Reuters rates hospitals' cardiovascular program

FDA recommends removal of breast cancer indication from Avastin label

FDA recommends removal of breast cancer indication from Avastin label

Miracor granted CE-Mark for PICSO Impulse System to improve ACS revascularization following PCI

Miracor granted CE-Mark for PICSO Impulse System to improve ACS revascularization following PCI

Study finds occurrence of infection following surgical procedures

Study finds occurrence of infection following surgical procedures

Nation's leading health care systems collaborate to improve quality while reducing costs

Nation's leading health care systems collaborate to improve quality while reducing costs

FDA to review Lantheus' DEFINITY sNDA for use in stress echocardiography

FDA to review Lantheus' DEFINITY sNDA for use in stress echocardiography

U-M's participation in Medicare Physician Group Practice Demonstration Project helps save over $15 million

U-M's participation in Medicare Physician Group Practice Demonstration Project helps save over $15 million

Pfizer withdraws Thelin for treatment of PAH, discontinues global clinical studies

Pfizer withdraws Thelin for treatment of PAH, discontinues global clinical studies

HeartWare prices public offering of convertible senior notes due 2017

HeartWare prices public offering of convertible senior notes due 2017

Serodus licenses selective serotonin-4 antagonist for potential heart failure treatment from Roche

Serodus licenses selective serotonin-4 antagonist for potential heart failure treatment from Roche

Aromatase inhibitors raise risk of cardiovascular disease in postmenopausal breast cancer patients

Aromatase inhibitors raise risk of cardiovascular disease in postmenopausal breast cancer patients

Warfarin may not be beneficial to some patients with atrial fibrillation: Researchers

Warfarin may not be beneficial to some patients with atrial fibrillation: Researchers

Acorda initiates enrollment in GGF2 Phase 1 clinical trial in patients with heart failure

Acorda initiates enrollment in GGF2 Phase 1 clinical trial in patients with heart failure

HeartWare announces $100 million convertible senior notes offering

HeartWare announces $100 million convertible senior notes offering

Sunovion reports results of Latuda third phase 3 worldwide clinical trial for schizophrenia

Sunovion reports results of Latuda third phase 3 worldwide clinical trial for schizophrenia

Bioheart group to advance BRIDGE TO RECOVERY clinical trial

Bioheart group to advance BRIDGE TO RECOVERY clinical trial

Poorly educated people more likely to be admitted in hospital with chronic heart failure

Poorly educated people more likely to be admitted in hospital with chronic heart failure

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.